Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Marek

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 28, 2025
Reply to: "Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS])"Tanya Simuni, Lana M Chahine, Kathleen L Poston, et al.
Neurology|April 25, 2014
Longitudinal follow-up of SWEDD subjects in the PRECEPT StudyKenneth Marek, John Seibyl, Shirley Eberly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Annals of Neurology|November 28, 2025
Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior DisorderShijun Yan, Anis Sahoo, Tanja Zerenner, et al.
Neurology|February 27, 2023
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderMichael C Brumm, Kerri A Pierz, David-Erick Lafontant, et al.
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Brain : a Journal of Neurology|July 26, 2015
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's diseaseZahi Qamhawi, David Towey, Bina Shah, et al.
Neurology|October 11, 2022
Planning for Prevention of Parkinson Disease: Now Is the TimeGrace F Crotty, Jessi L Keavney, Roy N Alcalay, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging studyYili Shang, Megan A Gibbs, Gerard J Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2007
Role of DAT-SPECT in the diagnostic work up of parkinsonismChristoph Scherfler, Johannes Schwarz, Angelo Antonini, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|June 28, 2025
Reply to: "Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS])"Tanya Simuni, Lana M Chahine, Kathleen L Poston, et al.
Neurology|April 25, 2014
Longitudinal follow-up of SWEDD subjects in the PRECEPT StudyKenneth Marek, John Seibyl, Shirley Eberly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Annals of Neurology|November 28, 2025
Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior DisorderShijun Yan, Anis Sahoo, Tanja Zerenner, et al.
Neurology|February 27, 2023
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderMichael C Brumm, Kerri A Pierz, David-Erick Lafontant, et al.
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Brain : a Journal of Neurology|July 26, 2015
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's diseaseZahi Qamhawi, David Towey, Bina Shah, et al.
Neurology|October 11, 2022
Planning for Prevention of Parkinson Disease: Now Is the TimeGrace F Crotty, Jessi L Keavney, Roy N Alcalay, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging studyYili Shang, Megan A Gibbs, Gerard J Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2007
Role of DAT-SPECT in the diagnostic work up of parkinsonismChristoph Scherfler, Johannes Schwarz, Angelo Antonini, et al.
Pageof 15